187 related articles for article (PubMed ID: 34947995)
1. Evaluation of the Role of p53 Tumour Suppressor Posttranslational Modifications and TTC5 Cofactor in Lung Cancer.
Alhebshi H; Tian K; Patnaik L; Taylor R; Bezecny P; Hall C; Muller PAJ; Safari N; Creamer DPM; Demonacos C; Mutti L; Bittar MN; Krstic-Demonacos M
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947995
[TBL] [Abstract][Full Text] [Related]
2. TTC5 is required to prevent apoptosis of acute myeloid leukemia stem cells.
Lynch JT; Somerville TD; Spencer GJ; Huang X; Somervaille TC
Cell Death Dis; 2013 Apr; 4(4):e573. PubMed ID: 23559008
[TBL] [Abstract][Full Text] [Related]
3. TRIP13 interference inhibits the proliferation and metastasis of thyroid cancer cells through regulating TTC5/p53 pathway and epithelial-mesenchymal transition related genes expression.
Yu L; Xiao Y; Zhou X; Wang J; Chen S; Peng T; Zhu X
Biomed Pharmacother; 2019 Dec; 120():109508. PubMed ID: 31648166
[TBL] [Abstract][Full Text] [Related]
4. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
[TBL] [Abstract][Full Text] [Related]
5. Human TTC5, a novel tetratricopeptide repeat domain containing gene, activates p53 and inhibits AP-1 pathway.
Xiong Y; Wang L; Deng W; Wang J; Shi T
Mol Biol Rep; 2013 Nov; 40(11):6183-8. PubMed ID: 24091941
[TBL] [Abstract][Full Text] [Related]
6. Regulation of glucocorticoid receptor activity by a stress responsive transcriptional cofactor.
Davies L; Paraskevopoulou E; Sadeq M; Symeou C; Pantelidou C; Demonacos C; Krstic-Demonacos M
Mol Endocrinol; 2011 Jan; 25(1):58-71. PubMed ID: 21147850
[TBL] [Abstract][Full Text] [Related]
7. TSPYL2 is a novel regulator of SIRT1 and p300 activity in response to DNA damage.
Magni M; Buscemi G; Maita L; Peng L; Chan SY; Montecucco A; Delia D; Zannini L
Cell Death Differ; 2019 May; 26(5):918-931. PubMed ID: 30050056
[TBL] [Abstract][Full Text] [Related]
8. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
[TBL] [Abstract][Full Text] [Related]
9. Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients.
Tseng RC; Lee CC; Hsu HS; Tzao C; Wang YC
Neoplasia; 2009 Aug; 11(8):763-70. PubMed ID: 19649206
[TBL] [Abstract][Full Text] [Related]
10. HIPK2 modulates p53 activity towards pro-apoptotic transcription.
Puca R; Nardinocchi L; Sacchi A; Rechavi G; Givol D; D'Orazi G
Mol Cancer; 2009 Oct; 8():85. PubMed ID: 19828042
[TBL] [Abstract][Full Text] [Related]
11. Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients.
Grbesa I; Pajares MJ; Martínez-Terroba E; Agorreta J; Mikecin AM; Larráyoz M; Idoate MA; Gall-Troselj K; Pio R; Montuenga LM
PLoS One; 2015; 10(4):e0124670. PubMed ID: 25915617
[TBL] [Abstract][Full Text] [Related]
12. Hyperacetylation of the C-terminal domain of p53 inhibits the formation of the p53/p21 complex.
Kim U; Kim KS; Park JK; Um HD
Biochem Biophys Res Commun; 2022 Dec; 635():52-56. PubMed ID: 36257192
[TBL] [Abstract][Full Text] [Related]
13. PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6.
Wan J; Xu W; Zhan J; Ma J; Li X; Xie Y; Wang J; Zhu WG; Luo J; Zhang H
Nucleic Acids Res; 2016 Dec; 44(22):10662-10675. PubMed ID: 27613418
[TBL] [Abstract][Full Text] [Related]
14. Sirtuin 3 induces apoptosis and necroptosis by regulating mutant p53 expression in small‑cell lung cancer.
Tang X; Li Y; Liu L; Guo R; Zhang P; Zhang Y; Zhang Y; Zhao J; Su J; Sun L; Liu Y
Oncol Rep; 2020 Feb; 43(2):591-600. PubMed ID: 31894331
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells.
Collins HM; Abdelghany MK; Messmer M; Yue B; Deeves SE; Kindle KB; Mantelingu K; Aslam A; Winkler GS; Kundu TK; Heery DM
BMC Cancer; 2013 Jan; 13():37. PubMed ID: 23356739
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells.
Sun Y; Sun D; Li F; Tian L; Li C; Li L; Lin R; Wang S
Lung Cancer; 2007 Oct; 58(1):21-9. PubMed ID: 17624472
[TBL] [Abstract][Full Text] [Related]
17. Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients.
Noh SJ; Kang MJ; Kim KM; Bae JS; Park HS; Moon WS; Chung MJ; Lee H; Lee DG; Jang KY
Pathology; 2013 Oct; 45(6):574-80. PubMed ID: 24018803
[TBL] [Abstract][Full Text] [Related]
18. Aspirin acetylates wild type and mutant p53 in colon cancer cells: identification of aspirin acetylated sites on recombinant p53.
Ai G; Dachineni R; Kumar DR; Marimuthu S; Alfonso LF; Bhat GJ
Tumour Biol; 2016 May; 37(5):6007-16. PubMed ID: 26596838
[TBL] [Abstract][Full Text] [Related]
19. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
[TBL] [Abstract][Full Text] [Related]
20. Human EHMT2/G9a activates p53 through methylation-independent mechanism.
Rada M; Vasileva E; Lezina L; Marouco D; Antonov AV; Macip S; Melino G; Barlev NA
Oncogene; 2017 Feb; 36(7):922-932. PubMed ID: 27452519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
